Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
97.88
+0.94 (0.97%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Zimmer Biomet Holdings Employees
Zimmer Biomet Holdings had 17,000 employees as of December 31, 2024. The number of employees decreased by 1,000 or -5.56% compared to the previous year.
Employees
17,000
Change (1Y)
-1,000
Growth (1Y)
-5.56%
Revenue / Employee
$451,682
Profits / Employee
$53,165
Market Cap
19.49B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17,000 | -1,000 | -5.56% |
Dec 31, 2023 | 18,000 | 0 | - |
Dec 31, 2022 | 18,000 | -1,500 | -7.69% |
Dec 31, 2021 | 19,500 | -500 | -2.50% |
Dec 31, 2020 | 20,000 | 100 | 0.50% |
Dec 31, 2019 | 19,900 | 900 | 4.74% |
Dec 31, 2018 | 19,000 | 800 | 4.40% |
Dec 31, 2017 | 18,200 | -300 | -1.62% |
Dec 31, 2016 | 18,500 | 1,000 | 5.71% |
Dec 31, 2015 | 17,500 | 7,500 | 75.00% |
Dec 31, 2014 | 10,000 | 500 | 5.26% |
Dec 31, 2013 | 9,500 | 200 | 2.15% |
Dec 31, 2012 | 9,300 | 600 | 6.90% |
Dec 31, 2011 | 8,700 | -100 | -1.14% |
Dec 31, 2010 | 8,800 | 600 | 7.32% |
Dec 31, 2009 | 8,200 | -300 | -3.53% |
Dec 31, 2008 | 8,500 | 900 | 11.84% |
Dec 31, 2007 | 7,600 | 700 | 10.14% |
Dec 31, 2006 | 6,900 | 200 | 2.99% |
Dec 31, 2005 | 6,700 | 100 | 1.52% |
Dec 31, 2004 | 6,600 | 100 | 1.54% |
Dec 31, 2003 | 6,500 | 2,900 | 80.56% |
Dec 31, 2002 | 3,600 | 200 | 5.88% |
Dec 31, 2001 | 3,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ZBH News
- 9 days ago - Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results - PRNewsWire
- 17 days ago - PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA - Business Wire
- 18 days ago - Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System - PRNewsWire
- 5 weeks ago - Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act - Business Wire
- 5 weeks ago - Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting - PRNewsWire
- 6 weeks ago - Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur - PRNewsWire
- 6 weeks ago - Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer - PRNewsWire
- 7 weeks ago - Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - PRNewsWire